Anatomic Pathology Market 2023: Trends, Business Growth And Major Driving Factors

Anatomic Pathology Market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. Anatomic pathology is a key part of the healthcare industry, providing detailed information about the diagnosis and treatment of diseases. The global anatomic pathology market is expected to grow significantly over the next few years, driven by factors such as the growing prevalence of chronic diseases and the development of innovative technologies for disease diagnosis and treatment.

The global anatomic pathology market is segmented into grossing and staining, reagents and consumables, instruments, and software and services. Grossing and staining is the largest segment and is expected to maintain its dominance during the forecast period due to the increasing demand for tissue-based diagnosis. Reagents and consumables are also expected to witness significant growth due to the growing demand for automated and advanced testing systems.

The growing focus on personalized medicine and the development of new and advanced technologies for disease diagnosis and treatment are some of the key trends driving the growth of the global anatomic pathology market. Additionally, the growing demand for precision medicine and the increasing awareness about the importance of early diagnosis of diseases are some of the other factors propelling the growth of the market.

Get a sample of the report:  https://www.prnewswire.com/news-releases/anatomic-pathology-market-worth-49-1-billion-by-2026--exclusive-report-by-marketsandmarkets-301414165.html

Top Lading Players: F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan)

Some Key Highlights from the Report:

1. The global anatomic pathology market is expected to grow at a CAGR of 7.0% during the forecast period, 2020-2027.

2. The key factors driving the growth of the anatomic pathology market include the rising prevalence of cancer, growing geriatric population, the development of advanced pathology solutions, and the increasing demand for personalized medicine.

3. Based on technology, the molecular diagnostics segment is estimated to grow at the highest CAGR of 4.2% during the forecast period.

4. The immunohistochemistry segment is expected to hold the largest market share.

5. Based on application, the oncology segment is estimated to grow at the highest CAGR of 3.8% during the forecast period.

6. North America is expected to hold the largest market share and is also estimated to grow at the highest CAGR of 4.1% during the forecast period.

Segments covered in the report:

By Product and Service

• Services
• Consumables
• Instruments

By Application

• Disease Diagnostics
• Medical Research

By End User

• Hospital Laboratories
• Clinical Laboratories
• Other End Users

Ask for Customize Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=137323145

Regional Outlook:

• North America (U.S.A., Canada, Mexico)
• Europe (Italy, U.K., Germany, France, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Addressed in the Report:

1. What are the dominating factors that are influencing the growth of the industry?
2. In the forecast period, which market segment is expected to rise the most?
3. What are the risks and challenges that the industry is facing?
4. In the coming years, which area is projected to dominate the market?
5. Who are the major players in the market?
6. What kind of strategic business plans have they made?

Make an inquiry to Buy this Report  @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=137323145

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Article source: https://article-realm.com/article/Health-Fitness/Exercise/41513-Anatomic-Pathology-Market-2023-Trends-Business-Growth-And-Major-Driving-Factors.html